Drug Profile
HGP 1201
Alternative Names: HGP1201Latest Information Update: 27 Apr 2023
Price :
$50
*
At a glance
- Originator Hanmi Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 27 Apr 2023 Discontinued - Preclinical for Unspecified in South Korea (unspecified route)
- 28 Oct 2018 No recent reports of development identified for preclinical development in Undefined in South Korea
- 24 Sep 2014 Preclinical trials in Undefined indication in South Korea (unspecified route)